Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Appelbaum

Showing results (231-240 of 490) with videos related to

Pageof 49
Sort By:
Leukemia|July 1, 1995
Carboplatin infusion in relapsed and refractory acute myeloid leukemia--a Southwest Oncology Group trialJ L Welborn, K J Kopecky, F J Meyers, et al.
Blood|June 15, 1995
Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center studyR A Nash, R Etzioni, R Storb, et al.
Bone Marrow Transplantation|January 1, 1992
Changing trends in marrow transplantation for aplastic anemiaR Storb, G Longton, C Anasetti, et al.
Transplantation|January 27, 1996
Gamma radiation of blood products prevents rejection of subsequent DLA-identical marrow grafts. Tolerance versus abrogation of sensitization to non-DLA antigensM A Bean, T Graham, F R Appelbaum, et al.
Leukemia|August 29, 2012
The proportion of CD34(+)CD38(low or neg) myeloblasts, but not side population frequency, predicts initial response to induction therapy in patients with newly diagnosed acute myeloid leukemiaM Roshal, S Chien, M Othus, et al.
Bone Marrow Transplantation|January 1, 1991
Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemiaC D Buckner, R A Clift, F R Appelbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Phase I/II trial of PIXY321 to enhance engraftment following autologous bone marrow transplantation for lymphoid malignancyJ M Vose, J E Anderson, P J Bierman, et al.
Bone Marrow Transplantation|October 1, 1996
Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemiaR Huss, H J Deeg, T Gooley, et al.
Bone Marrow Transplantation|February 1, 1995
Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or bothI Langenmayer, C Weaver, C D Buckner, et al.
Leukemia|June 14, 2013
Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD AndersonM Othus, H Kantarjian, S Petersdorf, et al.
Pageof 49

Showing results (231-240 of 490) with videos related to

Sort By:
Pageof 49
Leukemia|July 1, 1995
Carboplatin infusion in relapsed and refractory acute myeloid leukemia--a Southwest Oncology Group trialJ L Welborn, K J Kopecky, F J Meyers, et al.
Blood|June 15, 1995
Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center studyR A Nash, R Etzioni, R Storb, et al.
Bone Marrow Transplantation|January 1, 1992
Changing trends in marrow transplantation for aplastic anemiaR Storb, G Longton, C Anasetti, et al.
Transplantation|January 27, 1996
Gamma radiation of blood products prevents rejection of subsequent DLA-identical marrow grafts. Tolerance versus abrogation of sensitization to non-DLA antigensM A Bean, T Graham, F R Appelbaum, et al.
Leukemia|August 29, 2012
The proportion of CD34(+)CD38(low or neg) myeloblasts, but not side population frequency, predicts initial response to induction therapy in patients with newly diagnosed acute myeloid leukemiaM Roshal, S Chien, M Othus, et al.
Bone Marrow Transplantation|January 1, 1991
Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemiaC D Buckner, R A Clift, F R Appelbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Phase I/II trial of PIXY321 to enhance engraftment following autologous bone marrow transplantation for lymphoid malignancyJ M Vose, J E Anderson, P J Bierman, et al.
Bone Marrow Transplantation|October 1, 1996
Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemiaR Huss, H J Deeg, T Gooley, et al.
Bone Marrow Transplantation|February 1, 1995
Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or bothI Langenmayer, C Weaver, C D Buckner, et al.
Leukemia|June 14, 2013
Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD AndersonM Othus, H Kantarjian, S Petersdorf, et al.
Pageof 49